Terns Pharmaceuticals, Inc. (TERN) Tops Q1 EPS by 4c

Terns Pharmaceuticals, Inc. (NASDAQ: TERN) reported Q1 EPS of ($0.26), $0.04 better than the analyst estimate of ($0.30).

For earnings history and earnings-related data on Terns Pharmaceuticals, Inc. (TERN) click here.

You May Also Be Interested In

• Raymond James on Whirlpool Corporation (WHR): 'July Major Appliance Industrial Production Remained Weak'
• U.S. refiners boost crude oil intake to highest level since 2019
• Benchmark Reiterates Hold Rating on iQIYI (IQ) Following Q2 Earnings, Revenue Miss